4 things to know about VolitionRX's CRC blood test system & its sale in the US

VolitionRX, a developer of blood tests that can predict colon cancer, is looking to start selling the blood test system in the United States in the next year or so, according to a Benzinga report.

Here are four things to know:

1. VolitionRX's system works by collecting a blood sample from a patient.

2. The sample is analyzed for cancer specific nucleosome patterns and structures.

3. The company has been awarded numerous patents for the detection of nucleosomes.

4. VolitionRX has been approved to start selling the product in Europe.

More articles on GI/endoscopy:
Innovative colorectal cancer screening methods for remote areas
FDA clears 5 GI/endoscopy devices in December
US Endoscopy acquires Bracco Diagnostics' GI business unit

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months